CTLA-4
A molecule on T cells that acts as a brake, coming up at the end of the expansion phase to stop the immune response; Allison's lab showed blocking it lets T cells keep attacking tumors long enough to win.
As defined in 303 | James P. Allison on Fighting Cancer with the Immune System
Where it comes up · 1
Most important claims · 4 of 4Search all claims for “CTLA-4” →
- CTLA-4, which others had assumed was an activating 'gas pedal' molecule because adding antibody to it in culture increased T cells, was actually shown by Allison's lab in the early 1990s to be a brake: it comes up at the end of the T cell expansion phase to stop the response so it doesn't consume all the body's nutrients or harm it—and blocking this brake lets T cells keep going long enough to wipe out the tumor before normalcy returns.303 | James P. Allison on Fighting Cancer with the Immune System
- The anti-CTLA-4 antibody ipilimumab, approved by the FDA in 2011, cures about 20% of people with metastatic melanoma with one or two infusions—a disease in which previously no drug had ever had any effect, median survival was seven months, and fewer than 3% survived to five years; now 20% are alive at 10+ years with a single round of therapy.303 | James P. Allison on Fighting Cancer with the Immune System
- Combining the anti-CTLA-4 checkpoint blockade with anti-PD-1 (a different checkpoint discovered by Tasuku Honjo, Arlene Sharp, and Gordon Freeman) produced, in a gold-standard randomized trial of over a thousand patients across 10 countries with 10-year follow-up, 55% of metastatic melanoma patients still alive—transforming an almost uniformly fatal disease into one where more than half are cured.303 | James P. Allison on Fighting Cancer with the Immune System
- Calling the anti-CTLA-4 antibody 'the drug' is a disservice—it is really a pro-drug; the actual therapeutic agent is the T cell, which is why the antibody clears the body in a few weeks while the protective T cells persist for the rest of the patient's life, providing lasting protection like a vaccine.303 | James P. Allison on Fighting Cancer with the Immune System